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Inserted Central Catheters: A Systematic Review and Meta-analysis
Chopra V, Anand S, Hickner A, et al. Lancet 2013;382:311-25.
Conclusions: Peripherally inserted central catheters (PICCs) are asso-
ciated with a higher risk of venous thromboembolism (VTE) but not a
higher risk of pulmonary embolism (PE) than central venous catheters
(CVCs). VTE risk is greatest in those who are critically ill or with cancer.
Summary: Use of PICC lines has increased dramatically secondary to
many associated therapeutic applications and increasing availability of nurse-
led PICC teams for PICC insertion. PICCs are known to be associated with
venous thrombosis. However, their relative risk compared with other forms
of CVCs is unknown. Understanding this risk may be important to assessing
costs and patient safety questions. The authors therefore performed a sys-
tematic review and meta-analysis to quantitate PICC risks for VTE
compared with other forms of CVCs. They also sought to determine the fre-
quency of PICC-related VTE in speciﬁc patient populations. The study was
conducted by searching databases that included MEDLINE, EMBASE,
BIOSIS, Cochrane Central Register of Controlled Trials, Conference Pa-
pers Index, and Scopus. Studies were also identiﬁed through hand searches
of bibliographies as well as Internet searches. In addition, the authors con-
tacted study authors to obtain unpublished data. Any human study pub-
lished in full text, abstract, or poster form was eligible. All studies were of
adult patients at least 18 years of age with PICC lines. The Newcastle-
Ottawa risk of bias scale was used to assess study bias. The pooled frequency
of VTE was calculated for patients receiving PICCs in studies without a
comparison group. In studies that compared PICCs with other CVCs,
odds ratios (ORs) for VTE were calculated using a random-effects meta-
analysis model. The authors identiﬁed 533 citations. Of these, 64 studies,
52 without and 12 with a comparison group, met eligibility criteria. There
were 29,503 patients analyzed in the 64 studies. In the noncomparison
studies, weighted frequency of PICC-related VTE was highest in patients
who were critically ill (13.91%; 95% conﬁdence interval [CI], 7.68%-
20.14%) and among those with cancer (6.67%; 95% CI, 4.69%-8.64%). In
the studies comparing the risk of VTE related to PICCs compared with
CVCs, PICCs were associated with an increased risk of VTE (OR, 2.55;
95% CI, 1.54-4.23; P < .0001). There were no PEs associated with PICCs.
Using the baseline PICC-VTE rate of 2.7% and a pooled OR of 2.55, the
authors concluded the number needed to harm with PICCs compared
with CVCs was 26 (95% CI, 13-71).
Comment: The fact PICCs are associated with high rates of VTE,
particularly in critically ill and cancer patients, is not surprising. It is also
not particularly surprising that PICCs are associated with a higher rate of
VTE than CVCs. It is intriguing that PICCs in this large study of
>29,000 patients were not associated with a single known case of PE.
One wonders, therefore, whether PICC-associated deep venous thrombosis
should be considered an adverse patient safety outcome as deﬁned by
Agency for Healthcare Research and Quality. This may reﬂect a differing
natural history of upper extremity venous thrombosis compared with lower
extremity venous thrombosis or perhaps, as the authors speculate, more
frequent development of thrombophlebitis with PICCs resulting in a “phys-
iologic barrier” against proximal embolism. Other factors, such as veriﬁca-
tion of PICC tip positioning and use of smaller-gauge PICCs, as well as
perhaps the fact that deep venous thrombosis in the arm may be more clin-
ically evident and lead to earlier treatment than that of the leg, may also play
a role in the vanishingly small incidence of PE associated with PICCs.
A New Revised Cardiac Risk Index Incorporating Fragmented QRS
Complex as a Prognostic Marker in Patients Undergoing Noncardiac
Vascular Surgery
Bae MH, Jang SY, Choi WS, et al. Am J Cardiol 2013;112:122-7.
Conclusions: The presence of a fragmented QRS complex from a
12-lead electrocardiogram (ECG) adds to the predictive value of the
Revised Cardiac Risk Index (RCRI) for predicting major adverse cardiac
events in patients undergoing noncardiac vascular surgery.
Summary: The RCRI is advocated by the American College of Car-
diology/American Heart Association Guidelines for perioperative risk
assessment in patients undergoing noncardiac vascular surgery (FleisherLA et al, Circulation 2007;116:e418-99; and Lee TH et al, Circulation
1999;100:1043-9). However, it is well known that the RCRI has, in fact,
relatively limited ability to predict perioperative cardiac events (Parmar
CD et al, Vasc Endovasc Surg 2010;44:14-9). After acute coronary syn-
drome, a fragmented QRS (fQRS) complex on a 12-lead ECG can predict
cardiac events that include death and heart failure progression. The ability of
fQRS to predict cardiac events in high-risk patients undergoing noncardiac
vascular surgery is unknown. The aim of this study was therefore to inves-
tigate a new RCRI that included consideration of fQRS in patients under-
going noncardiac vascular surgery. There were 467 consecutive patients
undergoing noncardiac vascular surgery who were studied. Patients were
allocated to RCRI 0, 1, 2, or $3 groups according to the presence of dia-
betes, renal insufﬁciency, and histories of ischemic heart disease, congestive
heart failure, and cerebrovascular disease. After including a score of 1 or 0,
corresponding to the presence or absence of fQRS, patients were then real-
located to fragmented RCRI (fRCRI) 0, 1, 2, or $3. Major cardiac adverse
events (MACE) were deﬁned as a composite of death, myocardial infarction,
congestive heart failure, and percutaneous coronary intervention before
noncardiac vascular surgery. During the index hospitalization, MACE
developed in 38 patients (8.1%), and fQRS was present in 169 (36.2%). It
was more frequently present in patients with MACE than in those without
MACE (63.2 % vs 34.3%, P < .0001). Proportions of RCRI 0, 1, 2, and $3
were 46.9% (n ¼ 219), 35.3% (n ¼ 165), 12.4% (n ¼ 58), and 5.4% (n ¼
25), respectively. Including fRCRI data, 28 patients (48.3%) in RCRI 2
were reclassiﬁed as fRCRI $3. Multivariate logistic regression analysis
showed fRCRI independently predicted in-hospital MACE in patients
undergoing noncardiac vascular surgery (odds ratio, 1.529; 95% conﬁdence
interval, 1.035-2.258; P ¼ .003).
Comment: Inclusion of fQRS upgraded 6% of the patients in this
study to a level where noninvasive imaging would be recommended before
noncardiac vascular surgery. It increased the sensitivity of the RCRI $3 for
predicting MACE by 10.5%, but sensitivity was still only 31.6%. There is still
room for a great deal of improvement in predicting perioperative cardiac
events in vascular surgery patients.
Renal Function 5 Years After Open and Endovascular Aortic
Aneurysm Repair From a Randomized Trial
de Bruin JL, Vervloet MG, Buimer MG, and the DREAM study group. Br J
Surg 2013;100:1465-70.
Conclusions: After 5 years, renal function after open and endovascu-
lar abdominal aortic aneurysm (AAA) repair (EVAR) is similar. Neither pro-
cedure accelerates loss of renal function.
Summary: Renal dysfunction is a concern after AAA repair, and renal
dysfunction is a strong predictor of impaired survival after vascular surgery
(Patel VI et al, J Vasc Surg 2012;56:1206-13). Absence of infrarenal aortic
cross-clamping appears to reduce the risk of renal dysfunction after EVAR
(Walsh SR et al, J Endovasc Ther 2008;15:73-82). However, contrast-
enhanced computed tomography scanning for post-EVAR surveillance
may negate presumed advantages of EVAR for kidney function. The authors
therefore sought to compare renal function 5 years after open and endovas-
cular repair of AAA. The study represents a post hoc analysis of data
collected prospectively from the Dutch Randomized Endovascular Aneu-
rysm Management (DREAM) trial. Creatinine levels 5 years after surgery
were available for 189 patients (94 after open repair and 95 after EVAR).
The U.S. National Kidney Foundation clinical guidelines were used to stage
severity of chronic renal disease. The estimated glomerular ﬁltration rate
(eGFR) was estimated using the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) equation. Over time, eGFR for the entire group
declined, with a mean (standard deviation) preoperative value of 80.0 (7.6)
mL/min/1.73 m2 compared with 75.7 (9.7) mL/min/1.73 m2 after 5
years (mean difference, 4.2 [95% conﬁdence interval, 3.2-5.3] mL/min/
1.73 m2; P < .001). The mean eGFR 5 years after surgery was not signiﬁ-
cantly different between the open and endovascular groups: 76.3 (9.3) vs
75.1 (10.0) mL/min/1.73 m2 (P ¼ .410.)
Comment: Based on the National Health and Nutrition Examination
Survey III data, patients in the DREAM trial had lower preoperative mean
eGFR than age-matched, healthier counterparts (National Kidney Founda-
tion, Am J Kidney Dis 2002;39(Suppl 1):S1-266). However, the553
